Sayenko Kharenko acted as a legal counsel on obtaining merger clearance for the acquisition of Ferrosan’s consumer healthcare business by Pfizer Inc.

Sayenko Kharenko antitrust team has provided legal assistance in merger clearance with the Antimonopoly Committee of Ukraine (the "AMC") for USD 686 million acquisition by Pfizer Inc. ("Pfizer"), a US-based pharmaceutical manufacturer, of Ferrosan's consumer healthcare business ("FCH"), based in Denmark.

This transaction gave the opportunity for Pfizer to diversify its investment portfolio via participation in a high growth company and allowed FCH to expand its product offering using Pfizer's global footprint and continue improving and innovating its products portfolio.

Based in Copenhagen, Ferrosan is an innovative and long-established consumer healthcare company in the Nordic region with a portfolio of leading brands. Since 1920, Ferrosan has grown to serve a broader market including Russia, the Ukraine, Poland, Turkey and many countries throughout Central and Eastern Europe.

Pfizer, the world's largest research-based pharmaceutical company, discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands.

After the review of the proposed transaction, the AMC concluded that its implementation neither poses threats to competition nor significantly limits competition on any product market in Ukraine.

Sayenko Kharenko competition team for the current transaction included counsel Dmitry Taranyk and associate Maksym Nazarenko.

Related projects

24 January 2023


Sayenko Kharenko advises Goldman Sachs Asset Management on the acquisition of Cprime
23 January 2023


Sayenko Kharenko advises EBRD on EUR 25 million loan to the city of Lviv
12 January 2023


Sayenko Kharenko advised on the USD 895 million consent solicitation by Ukrainian Railways
Notification cookies

We use cookies to analyze the behavior of visitors
of our website and improve it. By using our website, you consent to these cookies in accordance with our Cookie Policy.